Ratings Goosehead Insurance, Inc

Equities

GSHD

US38267D1090

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-24 pm EDT			5-day change	1st Jan Change
64.36 ^USD	+7.50%		-0.02%	-15.09%

May. 24	TD Cowen Cuts Goosehead Insurance Price Target to $98 From $105, Maintains Buy Rating	MT
Apr. 30	Goosehead Insurance Insider Bought Shares Worth $580,650, According to a Recent SEC Filing	MT

Summary

From a short-term investment perspective, the company presents a deteriorated fundamental configuration.

Strengths

Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
The earnings growth currently anticipated by analysts for the coming years is particularly strong.
The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Historically, the company has been releasing figures that are above expectations.

Weaknesses

With an expected P/E ratio at 92.04 and 44.35 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
The company's "enterprise value to sales" ratio is among the highest in the world.
The company appears highly valued given the size of its balance sheet.
The valuation of the company is particularly high given the cash flows generated by its activity.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Multiline Insurance & Brokers

	1st Jan change	Capi.	ESG Refinitiv
GOOSEHEAD INSURANCE, INC	-15.09%	1.62B	C-
ARTHUR J. GALLAGHER & CO.	+12.09%	55.08B	B-
WILLIS TOWERS WATSON PUBLIC LIMITED COMPANY	+4.98%	25.89B	C+
BROWN & BROWN, INC.	+25.66%	25.49B	C
CAIXA SEGURIDADE PARTICIPAÇÕES S.A.	+21.01%	9.05B	-
RYAN SPECIALTY HOLDINGS, INC.	+27.75%	6.54B	-
STEADFAST GROUP LIMITED	-4.47%	4.11B	B
THE BALDWIN INSURANCE GROUP, INC.	+40.22%	2.23B	C-
AUB GROUP LIMITED	+3.21%	2.16B	C+
INSURANCE GROUP LIMITED	+28.91%	1.47B	-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes